Kelly Deck

Ms. Deck leads their accounting, finance, IT, and investor relations functions. She joined Inhibrx in October 2018, bringing over 15 years of experience in the life science industry. Before joining their team, Ms. Deck held various accounting and finance positions of increasing responsibility with Apricus Biosciences Inc., Hologic Inc., Gen-Probe Inc., and Cytori Therapeutics Inc. Ms. Deck holds a B.S. and M.S. in Accounting and is an active licensed Certified Public Accountant in the state of California.